Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.308
1.256 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.145,18 |
-0,3%
|
$1,08 T |
|
|
|
Johnson & Johnson
JNJ
|
$239,485 |
+3,2%
|
$576,49 B |
|
|
|
Roche Holding AG
ROG
|
CHf324,9 |
+4,1%
|
$329,60 B |
|
|
|
Merck & Co Inc
MRK
|
$117,655 |
-1,6%
|
$290,59 B |
|
|
|
Novartis AG
NOVN
|
CHf119,34 |
+1,7%
|
$285,46 B |
|
|
|
AstraZeneca PLC
AZN
|
GBX13.464 |
-2,4%
|
$278,73 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$43,5 |
+1,2%
|
$228,09 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr281,55 |
+3,5%
|
$192,76 B |
|
|
|
Pfizer Inc
PFE
|
$25,71 |
+0,4%
|
$146,53 B |
1.251 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
